Phase Ib, Open-label, Multicenter, Intrapatient Dose-escalation Clinical Trial to Assess the Safety Profile of the TN-TC11G (THC + CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Promoter: GEINO (SPANISH GROUP OF NEURONCOLOGY
- Phase: I
- Execution start: 10/08/2018
- End of execution: 30/09/2020
- PI: RAQUEL LUQUE CARO